Cargando…

Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma

Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent malignancy worldwide, with high incidence and poor survival rates. Increased expression of microRNA-205-5p (miR-205-5p) may influence the outcomes of HNSCC, but the identities of miR-205-5p target genes and the potential signa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ziyan, Liu, Chang, Liu, Kang, Lv, Meixin, Li, Baibei, Lan, Zhenrui, Chen, Wei, Kang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750893/
https://www.ncbi.nlm.nih.gov/pubmed/33327871
http://dx.doi.org/10.1177/1533033820980110
_version_ 1783625566997446656
author Zhou, Ziyan
Liu, Chang
Liu, Kang
Lv, Meixin
Li, Baibei
Lan, Zhenrui
Chen, Wei
Kang, Min
author_facet Zhou, Ziyan
Liu, Chang
Liu, Kang
Lv, Meixin
Li, Baibei
Lan, Zhenrui
Chen, Wei
Kang, Min
author_sort Zhou, Ziyan
collection PubMed
description Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent malignancy worldwide, with high incidence and poor survival rates. Increased expression of microRNA-205-5p (miR-205-5p) may influence the outcomes of HNSCC, but the identities of miR-205-5p target genes and the potential signaling pathways related to HNSCC remain unclear. RT-qPCR was used to detect the expression levels of miR-205-5p in the plasma of patients with HNSCC. We also performed a meta-analysis using data from relevant literature, and the Gene Expression Omnibus (GEO) and the Cancer Genome Atlas (TCGA) databases to evaluate the expression level of miR-205-5p in HNSCC. Next, we predicted the potential miR-205-5p target genes in HNSCC. We also used Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) for enrichment analyses adapted to investigate the dynamics and possible mechanisms of miR-205-5p in HNSCC. Lastly, we predicted the potential miR-205-5p target genes by evaluating their expression level and using Spearman analysis. Expression of miR-205-5p was higher in HNSCC tissues compared to normal unafflicted tissue samples (P < 0.05), and the corresponding summary receiver operating characteristic (sROC) was 0.82.The pooled sensitivity, specificity, PLR, NLR, and DOR values were 0.78 (95% CI: 0.75-0.81), 0.67 (95% CI: 0.60-0.73), 2.34 (95% CI: 1.45-3.76), 0.34 (95% CI: 0.19-0.60), and 8.16 (95% CI: 4.01-16.64), respectively. Based on GO and KEGG analyses, we found that miR-205-5p was correlated with the progression of HNSCC through association with signaling pathways, including the drug metabolism-cytochrome P450 pathway. Analysis of the target genes revealed that flavin-containing monooxygenase isoform 2 (FMO2) and alcohol dehydrogenase 1B (ADH1B) may be important targets of miR-205-5p. In summary, miR-205-5p may have a significant role in the prognosis of HNSCC and may serve as a potential biomarker in HNSCC.
format Online
Article
Text
id pubmed-7750893
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-77508932021-01-06 Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma Zhou, Ziyan Liu, Chang Liu, Kang Lv, Meixin Li, Baibei Lan, Zhenrui Chen, Wei Kang, Min Technol Cancer Res Treat Original Article Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent malignancy worldwide, with high incidence and poor survival rates. Increased expression of microRNA-205-5p (miR-205-5p) may influence the outcomes of HNSCC, but the identities of miR-205-5p target genes and the potential signaling pathways related to HNSCC remain unclear. RT-qPCR was used to detect the expression levels of miR-205-5p in the plasma of patients with HNSCC. We also performed a meta-analysis using data from relevant literature, and the Gene Expression Omnibus (GEO) and the Cancer Genome Atlas (TCGA) databases to evaluate the expression level of miR-205-5p in HNSCC. Next, we predicted the potential miR-205-5p target genes in HNSCC. We also used Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) for enrichment analyses adapted to investigate the dynamics and possible mechanisms of miR-205-5p in HNSCC. Lastly, we predicted the potential miR-205-5p target genes by evaluating their expression level and using Spearman analysis. Expression of miR-205-5p was higher in HNSCC tissues compared to normal unafflicted tissue samples (P < 0.05), and the corresponding summary receiver operating characteristic (sROC) was 0.82.The pooled sensitivity, specificity, PLR, NLR, and DOR values were 0.78 (95% CI: 0.75-0.81), 0.67 (95% CI: 0.60-0.73), 2.34 (95% CI: 1.45-3.76), 0.34 (95% CI: 0.19-0.60), and 8.16 (95% CI: 4.01-16.64), respectively. Based on GO and KEGG analyses, we found that miR-205-5p was correlated with the progression of HNSCC through association with signaling pathways, including the drug metabolism-cytochrome P450 pathway. Analysis of the target genes revealed that flavin-containing monooxygenase isoform 2 (FMO2) and alcohol dehydrogenase 1B (ADH1B) may be important targets of miR-205-5p. In summary, miR-205-5p may have a significant role in the prognosis of HNSCC and may serve as a potential biomarker in HNSCC. SAGE Publications 2020-12-17 /pmc/articles/PMC7750893/ /pubmed/33327871 http://dx.doi.org/10.1177/1533033820980110 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Zhou, Ziyan
Liu, Chang
Liu, Kang
Lv, Meixin
Li, Baibei
Lan, Zhenrui
Chen, Wei
Kang, Min
Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma
title Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma
title_full Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma
title_fullStr Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma
title_full_unstemmed Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma
title_short Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma
title_sort expression and possible molecular mechanisms of microrna-205-5p in patients with head and neck squamous cell carcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750893/
https://www.ncbi.nlm.nih.gov/pubmed/33327871
http://dx.doi.org/10.1177/1533033820980110
work_keys_str_mv AT zhouziyan expressionandpossiblemolecularmechanismsofmicrorna2055pinpatientswithheadandnecksquamouscellcarcinoma
AT liuchang expressionandpossiblemolecularmechanismsofmicrorna2055pinpatientswithheadandnecksquamouscellcarcinoma
AT liukang expressionandpossiblemolecularmechanismsofmicrorna2055pinpatientswithheadandnecksquamouscellcarcinoma
AT lvmeixin expressionandpossiblemolecularmechanismsofmicrorna2055pinpatientswithheadandnecksquamouscellcarcinoma
AT libaibei expressionandpossiblemolecularmechanismsofmicrorna2055pinpatientswithheadandnecksquamouscellcarcinoma
AT lanzhenrui expressionandpossiblemolecularmechanismsofmicrorna2055pinpatientswithheadandnecksquamouscellcarcinoma
AT chenwei expressionandpossiblemolecularmechanismsofmicrorna2055pinpatientswithheadandnecksquamouscellcarcinoma
AT kangmin expressionandpossiblemolecularmechanismsofmicrorna2055pinpatientswithheadandnecksquamouscellcarcinoma